HomeStock ScreenerBioconIntrinsic Value

Biocon Intrinsic Value

Biocon (BIOCON) median intrinsic value is ₹179.18 from 9 valuation models (range ₹125–₹903), vs current price ₹415.55 — -56.9% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit BIOCON share price.

Market Price (CMP)
₹415.55
Primary Intrinsic Value
₹124.66
Market Cap
₹337.0K Cr
-56.9% Downside
Median Value
₹179.18
Value Range
₹125 - ₹903
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

BIOCON Valuation Methods Summary — DCF, Graham Number & P/E

Biocon intrinsic value across 9 models vs current price ₹415.55 — upside/downside and value range per method. Read BIOCON dividend payout details for the complete payout history and dividend yield track record.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹124.66 ₹99.73 - ₹149.59 -70.0% EPS: ₹3.16, Sector P/E: 22x
Book Value Method asset ₹903.13 ₹812.82 - ₹993.44 +117.3% Book Value/Share: ₹451.57, P/B: 2.0x
Revenue Multiple Method revenue ₹447.55 ₹402.80 - ₹492.31 +7.7% Revenue/Share: ₹223.77, P/S: 2.0x
EBITDA Multiple Method earnings ₹473.49 ₹426.14 - ₹520.84 +13.9% EBITDA: ₹3840.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹322.83 ₹258.26 - ₹387.40 -22.3% CF Growth: 14.1%, Discount: 15%
PEG Ratio Method growth ₹124.66 ₹112.19 - ₹137.13 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹124.66 ₹112.19 - ₹137.13 -70.0% Revenue Growth: 6.0%, Adj P/E: 15.5x
Graham Defensive Method conservative ₹179.18 ₹161.26 - ₹197.10 -56.9% EPS: ₹3.16, BVPS: ₹451.57
Dividend Yield Method dividend ₹124.66 ₹112.19 - ₹137.13 -70.0% DPS: ₹0.50, Target Yield: 2.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

BIOCON Intrinsic Value vs Market Price — All Valuation Models

Biocon fair value range ₹125–₹903 vs current market price ₹415.55 across 9 valuation models. Compare with BIOCON fair price to assess whether the stock is under or overvalued.

BIOCON Intrinsic Value Analysis — Undervalued or Overvalued?

Biocon median intrinsic value ₹179.18, current price ₹415.55 — Trading Above Calculated Value by 56.9%, margin of safety -100.0%.

What is the intrinsic value of BIOCON?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Biocon (BIOCON) is ₹179.18 (median value). With the current market price of ₹415.55, this represents a -56.9% variance from our estimated fair value.

The valuation range spans from ₹124.66 to ₹903.13, indicating ₹124.66 - ₹903.13.

Is BIOCON undervalued or overvalued?

Based on our multi-method analysis, Biocon (BIOCON) appears to be trading above calculated value by approximately 56.9%.

BIOCON Financial Health — Key Ratios vs Industry Benchmarks

Biocon financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 1.33 Industry Standard: 2.0+ Below 1.5 Measures short-term liquidity capacity
Return on Equity 2.2% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 20.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.29x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

BIOCON Cash Flow Quality — Operating & Free Cash Flow

Biocon operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹1,994 Cr ₹1,053 Cr Positive Free Cash Flow 8/10
March 2025 ₹4,061 Cr ₹3,960 Cr Positive Free Cash Flow 8/10
March 2024 ₹2,954 Cr ₹2,453 Cr Positive Free Cash Flow 8/10
March 2023 ₹1,853 Cr ₹-5,277 Cr Positive Operating Cash Flow 6/10
March 2022 ₹1,177 Cr ₹346 Cr Positive Free Cash Flow 7/10